BiotechTube
Home/Vesper Bio/John King-Underwood
JK

John King-Underwood

Medicinal Chemistry Consultant

Vesper Bio

Therapeutic Areas

NeurologyOphthalmology

Vesper Bio Pipeline

DrugIndicationPhase
VES001Frontotemporal Degeneration (FTD-GRN)Phase 2
Sortilin Inhibitor ProgramParkinson's DiseasePreclinical

Leadership Team at Vesper Bio

AN
Anders Nykjær
Founder
AM
Andy Mulvaney
Business Development Consultant
GW
Graham Wynne
Medicinal Chemistry Consultant
View full Vesper Bio profile